Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GUMM - Eliminate the Common Cold -- Ignore unavailable to you. Want to Upgrade?

To: Tatnic who wrote (3623)	1/20/2001 9:05:19 AM
From: Mike M	Read Replies (1) \| Respond to of 5582

You, of course, have been right about 10...It was a crucial support and remains a formidable enough barrier. Probably will take a fairly significant news event to generate the volume to break through 10. There is plenty of potential for that. Either GUMM executes their business plan or they don't...

To: Tatnic who wrote (3623)	4/21/2002 1:34:55 PM
From: DanZ	Read Replies (4) \| Respond to of 5582

<If it breaks above 10 watch the volume...high vol. will mean its a real break.> Well, it took more than a year to break 10, but that's exactly what happened on Friday with GUMM closing at 10.09. This stock spent the last 15 months basing, with most of the volume between about 7 and 8.50. The short interest has declined 15 straight months, and now stands at 590,000, its lowest level since May 1997 after reaching an all time high in February 2000 (about 1.5 million). More than 100,000 shares traded in each of the last two trading sessions. While this is small compared to many stocks, it is more than twice GUMM's 30 day average of 42,000. The 30 day average had been hovering around 25,000 shares up until about a week ago. So what do you do now if you are short? a) Short more. b) Hold and hope it's just a fluke, and all the things that Gum Tech said in their last few press releases won't happen. c) Cover. I never believed that Picovir would be a serious threat to Zicam, but Mark made an issue out of it in Message 16803293. After the FDA Advisory Panel voted unanimously 15 to 0 to not recommend Picovir for approval, it's no longer an issue unless Viropharma gets a miracle. One more walk down memory lane in Message 15422380 <It also looks like they are winding down on Zicam as the next great thing and preparing to move on to the Nicotine gum as the product that will bring us to the brave new world.> Gum Tech said in several recent press releases that they are expanding distribution channels, including international, for the two Zicam products on the market, and plan to introduce product line extensions. Winding down doesn't accurately describe this.